BACKGROUND: Organ procurement organizations (OPOs) vary in willingness to pursue and utilize non-ideal donor lungs; implications of these practices for lung transplant (LTx) recipients remain unclear. We examined associations between OPO-level behavior toward non-ideal donors and post-LTx outcomes. METHODS: Adult lung donors and corresponding adult first-time LTx recipients in the 2008-2019 UNOS registry were included. Non-ideal donors had any of age > 50, smoking history ≥20 pack-years, PaO2 /FiO2 ratio ≤350, donation after circulatory death, or increased risk status. OPOs were classified as least, moderately, or most aggressive based on non-ideal donor pursuit, consent attainment, lung recovery, and transplantation. Post-transplant outcomes were compared among aggressiveness strata. RESULTS: Of 22,795 recipients, 6229 (27.3%), 8256 (36.2%), and 8310 (36.5%) received lungs from least, moderately, and most aggressive OPOs, respectively. Moderately aggressive OPOs had the highest recipient rates of pre-discharge acute rejection, grade 3 primary graft dysfunction, postoperative extracorporeal membrane oxygenation, and longest lengths of stay. After adjustment, moderately and most aggressive OPOs had similar risks of recipient mortality as least aggressive OPOs. CONCLUSIONS: The most and least aggressive OPOs achieve similar patient survival and short-term post-LTx outcomes. Aggressive pursuit and utilization of non-ideal donor lungs by less aggressive OPOs would likely expand the donor pool, without compromising recipient outcomes.
BACKGROUND: Organ procurement organizations (OPOs) vary in willingness to pursue and utilize non-ideal donor lungs; implications of these practices for lung transplant (LTx) recipients remain unclear. We examined associations between OPO-level behavior toward non-ideal donors and post-LTx outcomes. METHODS: Adult lung donors and corresponding adult first-time LTx recipients in the 2008-2019 UNOS registry were included. Non-ideal donors had any of age > 50, smoking history ≥20 pack-years, PaO2 /FiO2 ratio ≤350, donation after circulatory death, or increased risk status. OPOs were classified as least, moderately, or most aggressive based on non-ideal donor pursuit, consent attainment, lung recovery, and transplantation. Post-transplant outcomes were compared among aggressiveness strata. RESULTS: Of 22,795 recipients, 6229 (27.3%), 8256 (36.2%), and 8310 (36.5%) received lungs from least, moderately, and most aggressive OPOs, respectively. Moderately aggressive OPOs had the highest recipient rates of pre-discharge acute rejection, grade 3 primary graft dysfunction, postoperative extracorporeal membrane oxygenation, and longest lengths of stay. After adjustment, moderately and most aggressive OPOs had similar risks of recipient mortality as least aggressive OPOs. CONCLUSIONS: The most and least aggressive OPOs achieve similar patient survival and short-term post-LTx outcomes. Aggressive pursuit and utilization of non-ideal donor lungs by less aggressive OPOs would likely expand the donor pool, without compromising recipient outcomes.
Authors: Karl G Reyes; David P Mason; Lucy Thuita; Edward R Nowicki; Sudish C Murthy; Gösta B Pettersson; Eugene H Blackstone Journal: Ann Thorac Surg Date: 2010-06 Impact factor: 4.330
Authors: V van Suylen; B Luijk; R A S Hoek; E A van de Graaf; E A Verschuuren; C Van De Wauwer; J A Bekkers; R C A Meijer; W van der Bij; M E Erasmus Journal: Am J Transplant Date: 2017-05-30 Impact factor: 8.086
Authors: Gregory I Snell; Roger D Yusen; David Weill; Martin Strueber; Edward Garrity; Anna Reed; Andres Pelaez; Timothy P Whelan; Michael Perch; Remzi Bag; Marie Budev; Paul A Corris; Maria M Crespo; Chad Witt; Edward Cantu; Jason D Christie Journal: J Heart Lung Transplant Date: 2017-07-26 Impact factor: 10.247
Authors: Morgan L Cox; Michael S Mulvihill; Ashley Y Choi; Muath Bishawi; Asishana A Osho; John C Haney; Mani Daneshmand; Jacob A Klapper; Cameron R Wolfe; Matthew Hartwig Journal: J Heart Lung Transplant Date: 2018-12-21 Impact factor: 10.247
Authors: Paula Moreno; Antonio Alvarez; Francisco Santos; José Manuel Vaquero; Carlos Baamonde; Javier Redel; Francisco Cerezo; Francisco Javier Algar; Angel Salvatierra Journal: Eur J Cardiothorac Surg Date: 2013-10-25 Impact factor: 4.191
Authors: Sakhee Kotecha; Jamie Hobson; Jeremy Fuller; Eldho Paul; Bronwyn J Levvey; Helen Whitford; Miranda Paraskeva; David McGiffin; Gregory I Snell; Glen P Westall Journal: Ann Thorac Surg Date: 2017-09-28 Impact factor: 4.330
Authors: A K Israni; D Zaun; N Hadley; J D Rosendale; C Schaffhausen; W McKinney; J J Snyder; B L Kasiske Journal: Am J Transplant Date: 2020-01 Impact factor: 8.086
Authors: Samantha E Halpern; Alec McConnell; Sarah B Peskoe; Vignesh Raman; Oliver K Jawitz; Ashley Y Choi; Megan L Neely; Scott M Palmer; Matthew G Hartwig Journal: Am J Transplant Date: 2020-10-29 Impact factor: 8.086